US Edition
Your source for latest news
OpinionPublic Health

Opinion: Losing measles elimination status is a real failure, not a footnote

The Pan American Health Organization confirmed Nov. 17 that the United States, elimination-status holder since 2000, has lost that designation after a measles lineage circulated for more than a year amid a 2026 outbreak that topped 5,400 cases and 10 deaths. Treating the loss as a technicality, as some federal health officials have, is itself part of the problem.

PE
By PressTemps Editorial BoardPublished Today, 21:28 ET · 6 min read
Opinion: Losing measles elimination status is a real failure, not a footnote
File photo: a historical measles-vaccination campaign at the University of Mississippi. Credit: Mississippi Department of Archives and History, via Wikimedia Commons (no known copyright restrictions). Illustrative image, not from the 2026 outbreak.
What to know
PAHO confirmed Nov. 17, 2026 that the United States, along with Mexico and Bolivia, lost its measles-elimination status after a viral lineage circulated continuously for more than 12 months, ending a designation held since 2000.
The U.S. recorded more than 5,400 measles cases and 10 deaths in 2026, more than double the 2,289 cases in all of 2025, against a pre-2019 historical average of roughly 180 cases a year.
CDC data show kindergarten MMR vaccination coverage fell to 92.4% in the 2025-26 school year, below the 95% herd-immunity threshold, while nonmedical vaccine exemptions rose to 4.2% (about 155,000 children).
HHS asked PAHO to postpone the elimination-status review from April 2026 to November, after the midterm elections, prompting a formal Senate inquiry into whether the delay was politically timed.

The United States has not been a country where measles spreads on its own soil since the year 2000. That ended this week. On Nov. 17, the Pan American Health Organization confirmed that the United States, along with Mexico and Bolivia, has lost its measles-elimination status after an outbreak that began in West Texas in January 2025 produced a chain of transmission that never fully stopped. The technical trigger was narrow: the same viral lineage circulating, uninterrupted, for more than twelve months. The practical meaning is not narrow at all. It is the clearest marker yet that the country's immunization system, a quiet public-health achievement built over six decades, is coming apart faster than officials are willing to say out loud.

That matters because of what elimination status actually represented. It was not a trophy for having zero cases; the U.S. always imported a handful of infections a year from travelers. It meant that when a case arrived, it stayed contained — contact tracing, vaccination records, and herd immunity snuffed it out before it could become a self-sustaining chain. Losing the designation means that stopped working, in real time, in front of regulators whose only job is to measure it.

What the numbers show

The scale is not subtle. CDC's running tally put confirmed U.S. measles cases at more than 5,400 for 2026, with 10 deaths reported by state health departments — more than double the 2,289 cases recorded in all of 2025, which was itself the highest count since 1991. Against a pre-2019 baseline of roughly 180 cases a year, almost entirely imported, the current trajectory is not a bad season. It is a structural shift.

  • At least 48 distinct outbreaks were identified in 2026, with sustained spread in Pennsylvania, Wisconsin, Minnesota and Indiana after earlier outbreaks in South Carolina, Utah and Arizona; New York State declared a public-health emergency over its own cluster.
  • CDC school-vaccination data show kindergarten MMR coverage fell to 92.4% in the 2025-26 school year, down from roughly 95% before the pandemic — the threshold epidemiologists consider necessary for herd immunity against a virus this contagious.
  • The share of kindergartners with a vaccine exemption climbed to 4.2%, an estimated 155,000 children, driven almost entirely by nonmedical exemptions rather than medical ones, which have held near 0.2% for a decade.

Two doses of the MMR vaccine are about 97% effective. The arithmetic here is not mysterious: a virus that can infect nine of ten unvaccinated people exposed to it needs only a few percentage points of slack in coverage to find the room it needs.

The case for not panicking — and why it falls short

There is a real, non-cynical version of the argument that the designation itself is less important than the raw numbers suggest. Elimination status is a narrow technical classification, not a measure of an epidemic's severity, and 5,400 cases among a population of more than 340 million is still a small fraction of the country. Ralph Abraham, the CDC's newly appointed principal deputy director, made a version of this case to reporters, calling sustained transmission partly "the cost of doing business" with international travel and arguing that losing the status "does not mean that the measles would be widespread," as KFF Health News reported. He is not wrong that elimination is a specific epidemiological threshold rather than a synonym for crisis.

But the concession should stop there, because the threshold exists precisely to flag the thing that happened: a chain of transmission that domestic vaccination coverage was supposed to break within weeks, and instead ran for more than a year. Treating that as a rounding error, or as an inevitable byproduct of open borders, ignores that peer countries with comparable travel volumes did not lose their status this cycle, and that the U.S. outbreak took root specifically in communities with coverage well below the herd-immunity line. Jennifer Nuzzo of Brown University put the rebuttal plainly to KFF, arguing that fixating on the technical genetics of the designation is "the wrong priority" when the real task is stopping outbreaks. Paul Offit, who helped develop a rotavirus vaccine and has spent a career on measles policy, called the dismissiveness "callous," noting the 2000 elimination was something the country had earned and was supposed to protect.

"Elimination is not a trophy that we win once and put on a shelf," PAHO Director Jarbas Barbosa said in announcing the decision. "This is a serious warning for our Region, but it is not an irreversible setback."

Barbosa's framing is the right one: a warning, not a eulogy. The danger is a federal health leadership that treats it as neither — that absorbs the warning as a public-relations problem to be managed rather than a surveillance signal to be acted on.

A delay that raises its own questions

The timing of this announcement deserves scrutiny independent of the epidemiology. PAHO's review of U.S. elimination status was originally scheduled for April 2026, when experts widely expected the designation to be withdrawn. The Department of Health and Human Services asked PAHO to push the meeting to November — after the midterm elections. Sen. Lisa Blunt Rochester, a member of the Senate health committee, has since opened a formal inquiry, writing in a May 2026 letter to Secretary Robert F. Kennedy Jr. that cuts to CDC scientific staff may have contributed to the delay and that voters were denied information about the department's measles response before they went to the polls. Kennedy told the Senate HELP Committee in April that he had no role in the postponement; an HHS spokesperson had earlier said the delay was needed simply to finish analyzing the data. Those two accounts, as Blunt Rochester's office noted, do not obviously square with each other, and HHS has not resolved the discrepancy.

Whatever the explanation, a seven-month postponement of a technical public-health review, landing precisely on the other side of an election, is the kind of coincidence that invites exactly the skepticism it has received. Kennedy has separately said the U.S. will "work to regain" elimination status and continues to recommend the MMR vaccine, which is to the administration's credit. It does not resolve the question of why the bad news was scheduled for after voters had already cast ballots.

What happens next

Regaining elimination status requires twelve consecutive months without a sustained chain of the same lineage — a bar that resets every time a new outbreak takes hold, which is why Canada, which lost the designation in November 2025, has not yet earned it back. For the United States, with active transmission in multiple states simultaneously, that clock has not meaningfully started. Public-health reporting this month has made clear that outside researchers, not just government scientists, had to independently verify the genomic data behind the decision — a sign of how much trust in the official process has already eroded.

None of this requires a single new federal mandate to fix. States set school vaccination requirements, and most of the decline traces to a small number of states loosening nonmedical exemptions and a somewhat larger number of parents opting out. But federal leadership sets the tone, funds the surveillance, and decides whether a CDC spokesperson treats a lost public-health designation as a shrug or a siren. The CDC's own director has said the elimination label itself "is not what protects Americans" — vaccination is. That is true, and it is also an argument for urgency, not equanimity. The country spent 25 years earning a designation that signaled its vaccination system worked. It lost that designation this week because, in enough places, it stopped working. The right response is to say so plainly, fund the fix, and let the next review — whenever it is actually scheduled — be the one that counts.

More on this story

All Opinion